Tetra Bio-Pharma, Inc. engages in the discovery and development of cannabinoid-based drugs and treatments. The company was founded by Ryan Brown and Andre D. Audet on May 17, 2007 and is headquartered in Orleans, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Tetra Bio-Pharma Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tetra Bio-Pharma Inc market cap is $8.47M.
What is the 52-week high for Tetra Bio-Pharma Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tetra Bio-Pharma Inc 52 week high is $0.0001 as of October 10, 2025.
What is the 52-week low for Tetra Bio-Pharma Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tetra Bio-Pharma Inc 52 week low is $0.00 as of October 10, 2025.
What is the 50-day moving average of Tetra Bio-Pharma Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tetra Bio-Pharma Inc 50-day moving average is $0.00.